bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
May 26, 2015Five Prime Therapeutics and bluebird bio enter into an exclusive license agreement to research, develop and commercialize chimeric antigen receptor (CAR) T cell therapies using Five Prime's proprietary human antibodies to an undisclosed cancer target for
More »
U.K. Ophthalmologists Lead in Treatment of Wet AMD Patients with Oraya Therapy Across Europe
May 19, 2015Oraya Thereapeutics announces at the Royal College of Ophthalmologists Annual Congress that U.K. ophthalmologists are the leading adopters of Oraya Therapy for the treatment of Wet AMD.
More »
Tandem Diabetes Care Launches t:flex™ Insulin Pump
May 19, 2015Tandem Diabetes Care is now taking orders for the t:flex™ Insulin Pump, with shipments planned to begin in June. The 480-unit t:flex Pump is designed for people who require more than 80 units of U-100 insulin per day, such as teenagers with type 1 diabete
More »